4CELL THERAPIES SPÓŁKA AKCYJNA

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

07/02/2013

VAT status

Active

Bankruptcy proceedings

No proceedings

4CELL THERAPIES SPÓŁKA AKCYJNA

Contacts

Registered address

See on map

Website

WWW.4CELLTHERAPIES.COM

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated due to significantly decreased turnover, expert evaluation needed.

Incorporation date

01/09/2017

Share capital

2,446,741.50 PLN

Primary activity

Research and experimental development on biotechnology (72.11.Z - PKD 2007)

Representatives

Representatives rights

1. DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM. 2. JEŻELI ZARZĄD JEST JEDNOOSOBOWY, DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI UPRAWNIONY JEST JEDEN CZŁONEK ZARZĄDU.

Representatives

Chairman of the management boardP**** M***** W*********

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
P** M* W*******	Chairman of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

-2,577,574

Net Profit (zł)

-2,577,574

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
0
-3,121,807
-3,121,807
-
3.30
-
4,138,845
1,158,573
0
1,253,120

2023
0
-4,081,213
-4,081,213
-
1.14
-
2,557,633
746,734
0
1,072,944

2024
0
-2,577,574
-2,577,574
-
0.10
-
-19,942
3,507,879
0
709,728

2024
0
-2,577,574
-2,577,574
-
0.10
-
-19,942
3,507,879
0
709,728

Turnover (zł)

2024

Turnover (zł)

0 zł- *

Profit before tax (zł)

-2,577,574 zł37 % *

Net Profit (zł)

-2,577,574 zł37 % *

Working capital requirement (%)

Liquidity ratio

0.10 -91.23 % *

Net profitability (%)

Equity (zł)

-19,942 zł-101 % *

Current liabilities (zł)

3,507,879 zł370 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

709,728 zł-34 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Order report

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

4CELL THERAPIES SPÓŁKA AKCYJNA Documents

Date	Description
08/07/2025	OD 01.01.2024 DO 31.12.2024
12/07/2024	OD 01.08.2022 DO 31.12.2023
13/02/2023	OD 01.08.2021 DO 31.07.2022
25/01/2022	OD 01.08.2020 DO 31.07.2021
02/02/2021	OD 01.08.2019 DO 31.07.2020